diogenes
GLP-1 Apprentice
What do people think about β3 agonism -> brown fat activation -> higher RMR as a way to fight obesity?
As I understand, this was tried with mirabegron, but required up to 200mg to get a useful RMR boost, which caused too much norepinephrine interference and β1/β2 spillover (hypertension, tachycardia, etc). But it worked! Patients got a 200kcal/day boost, which is a lot.
I saw this study is being done with vibegron, a (patented) more specific β3 agonist: https://clinicaltrials.gov/study/NCT06987383. I guess the hope is that it could boost RMR without the side effects.
If this is true, it seems like it could be a useful adjunct to GLP-1 drugs. What do people think?
As I understand, this was tried with mirabegron, but required up to 200mg to get a useful RMR boost, which caused too much norepinephrine interference and β1/β2 spillover (hypertension, tachycardia, etc). But it worked! Patients got a 200kcal/day boost, which is a lot.
I saw this study is being done with vibegron, a (patented) more specific β3 agonist: https://clinicaltrials.gov/study/NCT06987383. I guess the hope is that it could boost RMR without the side effects.
If this is true, it seems like it could be a useful adjunct to GLP-1 drugs. What do people think?